Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both
- 24 December 1998
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (26) , 1889-1895
- https://doi.org/10.1056/nejm199812243392604
Abstract
Although trimethoprim–sulfamethoxazole is the drug of choice for the prevention of Pneumocystis carinii pneumonia, many patients cannot tolerate it and must switch to an alternative agent.Keywords
This publication has 15 references indexed in Scilit:
- Meta-Analysis of Prophylactic Treatments Against Pneumocystis carinii Pneumonia and Toxoplasma Encephalitis in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Prevention of Opportunistic Infections in the Era of Improved Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimensArchives of internal medicine (1960), 1996
- A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995
- Once-Weekly Administration of Dapsone/Pyrimethamine vs. Aerosolized Pentamidine as Combined Prophylaxis for Pneumocystis carinii Pneumonia and Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected PatientsClinical Infectious Diseases, 1995
- Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients with AIDSNew England Journal of Medicine, 1993
- Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individualsAIDS, 1993
- Prevention and Treatment of Pneumocystis PneumoniaNew England Journal of Medicine, 1992
- Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology GroupArchives of internal medicine (1960), 1992
- Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitisAntimicrobial Agents and Chemotherapy, 1990